fashion -WSS

fashion

author：Wikipedia 2025-09-28 21:11:17 - browse：844

A new lawsuit accuses the health insurer Cigna of denying claims in bulk. Julia Rendleman/Getty Images for Eventive Marketing

A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid.

The complaint filed Monday in the Eastern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments. The company then allegedly denies claims in bulk without looking into each coverage request. California law requires insurers to give each claim a “thorough, fair, and objective investigation.”

Once the claims are denied, the company allegedly has its physician reviewers sign off on batches of denials without opening each patient’s files to conduct detailed reviews. The complaint cites a March ProPublica article, which found that over a period of two months in 2022, Cigna doctors denied over 300,000 requests for payment using PXDX, spending an average of 1.2 seconds “reviewing” each request. One doctor alone denied 121,000 claims in that time period, according to the article.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： H5N1 bird flu virus started spreading in cows in Texas in December

WSS

Cell therapy fails to slow type 1 diabetes, but safety is established

Truvian presents data for its desktop blood

H5N1 bird flu virus started spreading in cows in Texas in December

Cholera vaccine supply gets boost as demand surges globally

The haunting brain science of long Covid

Roche’s Alnylam deal shows drug firms interested in heart drugs

explore

fashion

explore

How to save PrEP access — and even expand it

More tobacco lobbyists active in statehouses

Duchenne breakthrough therapy leaves behind pioneering families

Search called off for baby washed away in Pennsylvania flash flood

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The battle over 'scope creep' and who gets to be called 'doctor'

Cancer drug shortages should be causing more outrage

Getting Alzheimer's drug Leqembi to patients can be a challenge

United colonoscopy coverage change 'may cost lives,' doctors say

Senate panel puts off hardest PBM reforms for another day

focus

Former reverend arrested for allegedly killing 8

The battle over 'scope creep' and who gets to be called 'doctor'

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Cell therapy fails to slow type 1 diabetes, but safety is established

Melinda French Gates resigns from Gates Foundation

Senate panel puts off hardest PBM reforms for another day

hotspot

focus

leisure time

explore